A reasonable chance it could cause serious harm or death.
Presence of Particulate Matter: Product complaint for the presence of glass particles in a syringe.
| Brand name | OCTREOTIDE ACETATE |
| Generic name | OCTREOTIDE ACETATE |
| Active ingredient(s) | OCTREOTIDE ACETATE |
| Distributed by / for | Mylan Institutional LLC, Morgantown, WV 26505 U.S.A., Made in Italy |
| NDC | 67457-246-00 |
| Full product label | Octreotide Acetate Injection 500 mcg/mL, 10 x 1 mL Single-Dose Unit-of-Use Syringes, For Subcutaneous or Intravenous Use, Rx Only, Manufactured for: Mylan Institutional LLC, Morgantown, WV 26505 U.S.A., Made in Italy, NDC: 67457-246-00 (syringe), 67457-246-01 (carton). |
| Recalling firm | Viatris Inc |
| Distribution | Nationwide in the USA |
| Quantity | 22400 syringes |
| Recall initiated | 2022-10-07 |
| Report date | 2022-11-16 |
| Recall completed | 2024-01-12 |
| Recall number | D-0058-2023 |
| Classification | Class I |
| FDA status | Terminated |
| Origin on file | Canonsburg PA United States |
Source: U.S. FDA enforcement database (openFDA). Look this up on the official FDA recalls site ↗